A Scottish research firm is teaming up with a global leader in diagnostic technology for what is hoped to result in a “transformative” new blood test that would allow doctors to identify Alzheimer’s disease earlier.
Edinburgh-based Scottish Brain Sciences announced it is to collaborate with Roche Diagnostics on a series of major projects, which founder Professor Craig Ritchie said could have “big impacts”.
